Tus-Pharmaceutical Group Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 216.41 million compared to CNY 176.6 million a year ago. Revenue was CNY 216.41 million compared to CNY 176.6 million a year ago. Net income was CNY 39.07 million compared to CNY 19.33 million a year ago. Basic earnings per share from continuing operations was CNY 0.1631 compared to CNY 0.0807 a year ago. Diluted earnings per share from continuing operations was CNY 0.1631 compared to CNY 0.0807 a year ago.